{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T13:06:46Z","timestamp":1660309606801},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ethanol dependence is associated with a discontinuation withdrawal delirium. Chlordiazepoxide is frequently successfully used in its treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 27-year-old, Caucasian female with ethanol dependence who had objective symptoms of withdrawal experienced worsening of her delirium after administration of chlordiazepoxide, but improved with lorazepam and cleared with discontinuation of benzodiazepine administration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Worsening of delirium appears to be related to the specific use of chlordiazepoxide, but the mechanism of this effect is not clear. While this case does not alter the standard care of ethanol dependence, it does alert clinicians that our treatment approach may not be fully benign.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03456-x","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T10:10:44Z","timestamp":1657188644000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chlordiazepoxide-induced delirium in a patient undergoing alcohol withdrawal: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Melissa A.","family":"Arabadjief","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar H.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi R.","family":"Gundumalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek S.","family":"Menefee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody L.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayeem Z.","family":"Moulana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rif S.","family":"El-Mallakh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"3456_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bpa.2012.07.003","volume":"26","author":"EE Vasilevskis","year":"2012","unstructured":"Vasilevskis EE, Han JH, Hughes CG, Ely EW. Epidemiology and risk factors for delirium across hospital settings. Best Pract Res Clin Anaesthesiol. 2012;26:277\u201387.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"22","key":"3456_CR2","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMra1407298","volume":"371","author":"MA Schuckit","year":"2014","unstructured":"Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med. 2014;371(22):2109\u201313. https:\/\/doi.org\/10.1056\/NEJMra1407298.","journal-title":"N Engl J Med"},{"issue":"4","key":"3456_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jceh.2018.04.012","volume":"8","author":"S Grover","year":"2018","unstructured":"Grover S, Ghosh A. Delirium tremens: assessment and management. J Clin Exp Hepatol. 2018;8(4):460\u201370. https:\/\/doi.org\/10.1016\/j.jceh.2018.04.012.","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"3456_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1192\/bjp.bp.109.070797","volume":"197","author":"J Per\u00e4l\u00e4","year":"2010","unstructured":"Per\u00e4l\u00e4 J, Kuoppasalmi K, Pirkola S, H\u00e4rk\u00e4nen T, Saarni S, Tuulio-Henriksson A, et\u00a0al. Alcohol-induced psychotic disorder and delirium in the general population. Br J Psychiatry. 2010;197(3):200\u20136. https:\/\/doi.org\/10.1192\/bjp.bp.109.070797.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"3456_CR5","doi-asserted-by":"publisher","first-page":"CD006379","DOI":"10.1002\/14651858.CD006379.pub3","volume":"2009","author":"E Lonergan","year":"2009","unstructured":"Lonergan E, Luxenberg J, Areosa Sastre A. Benzodiazepines for delirium. Cochrane Database Syst Rev. 2009;2009(4):CD006379. https:\/\/doi.org\/10.1002\/14651858.CD006379.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3456_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s13181-014-0391-6","volume":"10","author":"PW Moore","year":"2014","unstructured":"Moore PW, Donovan JW, Burkhart KK, Waskin JA, Hieger MA, Adkins AR, et\u00a0al. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center. J Med Toxicol. 2014;10(2):126\u201332. https:\/\/doi.org\/10.1007\/s13181-014-0391-6.","journal-title":"J Med Toxicol"},{"issue":"6","key":"3456_CR7","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.1097\/ADM.0000000000000655","volume":"14","author":"RJ Elefante","year":"2020","unstructured":"Elefante RJ, Batkis M, Nelliot A, Abernathy K, Rocha K, Jenkins F, et\u00a0al. Psychometric properties of the Revised Clinical Institute Withdrawal Alcohol Assessment and the Brief Alcohol Withdrawal Scale in a psychiatric population. J Addict Med. 2020;14(6):e355\u20138. https:\/\/doi.org\/10.1097\/ADM.0000000000000655.","journal-title":"J Addict Med"},{"issue":"4","key":"3456_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s13181-014-0433-0","volume":"10","author":"S Lucyk","year":"2014","unstructured":"Lucyk S, von Schweinitz BA, Hoffman RS. In response to: safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center. J Med Toxicol. 2014;10(4):435. https:\/\/doi.org\/10.1007\/s13181-014-0433-0.","journal-title":"J Med Toxicol"},{"key":"3456_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005063.pub3","author":"L Amato","year":"2010","unstructured":"Amato L, Minozzi S, Vecchi S, Davoli M. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2010. https:\/\/doi.org\/10.1002\/14651858.CD005063.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"3456_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15373","volume":"13","author":"A Wang","year":"2021","unstructured":"Wang A, Park A, Albert R, Barriga A, Goodrich L, Nguyen BN, et\u00a0al. Iatrogenic delirium in patients on symptom-triggered alcohol withdrawal protocol: a case series. Cureus. 2021;13(6): e15373. https:\/\/doi.org\/10.7759\/cureus.15373.","journal-title":"Cureus"},{"issue":"1","key":"3456_CR11","volume":"5","author":"T Mehdi","year":"2012","unstructured":"Mehdi T. Benzodiazepines revisited. Br J Med Pract. 2012;5(1): a501.","journal-title":"Br J Med Pract"},{"issue":"1","key":"3456_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5507\/bp.2013.089","volume":"159","author":"B Mainerova","year":"2015","unstructured":"Mainerova B, Prasko J, Latalova K, Axmann K, Cerna M, Horacek R, et\u00a0al. Alcohol withdrawal delirium\u2014diagnosis, course and treatment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(1):44\u201352. https:\/\/doi.org\/10.5507\/bp.2013.089.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"5","key":"3456_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2165\/00003088-197803050-00004","volume":"3","author":"DJ Greenblatt","year":"1978","unstructured":"Greenblatt DJ, Shader RI, MacLeod SM, Sellers EM. Clinical pharmacokinetics of chlordiazepoxide. Clin Pharmacokinet. 1978;3(5):381\u201394. https:\/\/doi.org\/10.2165\/00003088-197803050-00004.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"3456_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/cpt1978235535","volume":"23","author":"PJ Perry","year":"1978","unstructured":"Perry PJ, Wilding DC, Fowler RC, Hepler CD, Caputo JF. Absorption of oral intramuscular chlordiazepoxide by alcoholics. Clin Pharmacol Therap. 1978;23(5):535\u201341. https:\/\/doi.org\/10.1002\/cpt1978235535.","journal-title":"Clin Pharmacol Therap"},{"issue":"Suppl.","key":"3456_CR15","first-page":"337","volume":"2","author":"D Nutt","year":"1993","unstructured":"Nutt D, Glue P, Wilson S, Groves S, Coupland N, Bailey J. Flumazenil in alcohol withdrawal. Alcohol Alcohol. 1993;2(Suppl.):337\u201341.","journal-title":"Alcohol Alcohol"},{"issue":"12","key":"3456_CR16","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jagp.2013.09.005","volume":"21","author":"JR Maldonado","year":"2013","unstructured":"Maldonado JR. Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatr Psychiatry. 2013;21(12):1190\u2013222. https:\/\/doi.org\/10.1016\/j.jagp.2013.09.005.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"3456_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/ageing\/afq140","volume":"40","author":"A Clegg","year":"2011","unstructured":"Clegg A, Young JB. Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing. 2011;40(1):23\u20139. https:\/\/doi.org\/10.1093\/ageing\/afq140.","journal-title":"Age Ageing"},{"issue":"7","key":"3456_CR18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1292\/jvms.11-0538","volume":"74","author":"M Okada","year":"2012","unstructured":"Okada M, Mizuno W, Nakarai R, Matada T, Yamawaki H, Hara Y. Benzodiazepines inhibit the acetylcholine receptor-operated potassium current (IK.ACh) by different mechanisms in guinea-pig atrial myocytes. J Vet Med Sci. 2012;74(7):879\u201384. https:\/\/doi.org\/10.1292\/jvms.11-0538.","journal-title":"J Vet Med Sci"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03456-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T10:16:54Z","timestamp":1657189014000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03456-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3456"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03456-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"assertion":[{"value":"16 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our institutional human subjects protection program allowed submission of this case presentation (IRB number 22.1081). Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no actual competing interests for this paper. However, Dr. El-Mallakh serves as a speaker for Indivior, Intracellular Therapies, Janssen, Lundbeck, Noven, Otsuka, Sunovion, and Teva. None of the other authors has any actual or perceived competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}